New hope for kids with tough blood cancers: trial tests targeted drug combo
NCT ID NCT07175415
Summary
This trial is testing a new combination of three drugs—capivasertib, venetoclax, and dexamethasone—for children and young adults whose leukemia or lymphoma has come back or hasn't responded to standard treatments. The main goals are to find the safest dose and see if this combination can help control the cancer. The study will enroll about 42 participants aged 2 to under 21 years old.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.